These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 228594)

  • 21. Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses.
    Gaudernak E; Seipelt J; Triendl A; Grassauer A; Kuechler E
    J Virol; 2002 Jun; 76(12):6004-15. PubMed ID: 12021333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new antirhinovirus compound, ICI 73602: structure, properties, and spectrum of activity.
    Swallow DL; Bucknall RA; Stanier WE; Hutchinson A; Gaskin H
    Ann N Y Acad Sci; 1977 Mar; 284(1):305-9. PubMed ID: 212977
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and antirhinovirus activity of 3-(diethylamino)-5-phenylisoxazole derivatives.
    Mazzei M; Garzoglio R; Balbi A; Grandi T; De Montis A; Corrias S; La Colla P
    Farmaco; 1996 May; 51(5):351-9. PubMed ID: 8767845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
    Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
    Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Amino-3-substituted-6-[(E)-1-phenyl-2-(N-methylcarbamoyl)vinyl]imid azo[1,2-a]pyridines as a novel class of inhibitors of human rhinovirus: stereospecific synthesis and antiviral activity.
    Hamdouchi C; de Blas J; del Prado M; Gruber J; Heinz BA; Vance L
    J Med Chem; 1999 Jan; 42(1):50-9. PubMed ID: 9888832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action of 2-furylmercury chloride, an anti-rhinovirus compound.
    Verheyden B; Andries K; Rombaut B
    Antiviral Res; 2004 Mar; 61(3):189-94. PubMed ID: 15168800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the biological activity of novel synthetic compounds with antiviral properties against human rhinoviruses.
    Laconi S; Madeddu MA; Pompei R
    Molecules; 2011 Apr; 16(5):3479-87. PubMed ID: 21522081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
    Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
    Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new compounds with promising antiviral properties against group A and B Human Rhinoviruses.
    Bernard AM; Cabiddu MG; De Montis S; Mura R; Pompei R
    Bioorg Med Chem; 2014 Aug; 22(15):4061-6. PubMed ID: 24973816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus.
    Heinz BA; Vance LM
    J Virol; 1995 Jul; 69(7):4189-97. PubMed ID: 7769678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral activity of a bis-benzimidazole against experimental rhinovirus infections in chimpanzees.
    Shipkowitz NL; Bower RR; Schleicher JB; Aquino F; Appell RN; Roderick WR
    Appl Microbiol; 1972 Jan; 23(1):117-22. PubMed ID: 4333893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses.
    Dewindt B; van Eemeren K; Andries K
    Antiviral Res; 1994 Sep; 25(1):67-72. PubMed ID: 7811059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VP4 protein from human rhinovirus 14 is released by pressure and locked in the capsid by the antiviral compound WIN.
    Gonçalves RB; Mendes YS; Soares MR; Katpally U; Smith TJ; Silva JL; Oliveira AC
    J Mol Biol; 2007 Feb; 366(1):295-306. PubMed ID: 17161425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antiviral activity of isoquinoline drugs for rhinoviruses in vitro and in vivo.
    Reed SE; Bynoe ML
    J Med Microbiol; 1970 May; 3(2):346-52. PubMed ID: 4318080
    [No Abstract]   [Full Text] [Related]  

  • 36. Iota-Carrageenan is a potent inhibitor of rhinovirus infection.
    Grassauer A; Weinmuellner R; Meier C; Pretsch A; Prieschl-Grassauer E; Unger H
    Virol J; 2008 Sep; 5():107. PubMed ID: 18817582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antirhinovirus activity of purine nucleoside analogs.
    De Clercq E; Bernaerts R; Bergstrom DE; Robins MJ; Montgomery JA; Holy A
    Antimicrob Agents Chemother; 1986 Mar; 29(3):482-7. PubMed ID: 3013084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
    Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
    J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.
    Diana GD; Volkots DL; Nitz TJ; Bailey TR; Long MA; Vescio N; Aldous S; Pevear DC; Dutko FJ
    J Med Chem; 1994 Jul; 37(15):2421-36. PubMed ID: 8057290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3,4-Dihydro-2-phenyl-2H-pyrano[2,3-b]pyridines with potent antirhinovirus activity.
    Bargar TM; Dulworth JK; Kenny MT; Massad R; Daniel JK; Wilson T; Sargent RN
    J Med Chem; 1986 Sep; 29(9):1590-5. PubMed ID: 3018241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.